Single cell analýza u pacientů s akutní myeloidní leukemií
DRNCOVÁ, Marie, A. FOLTA, Iveta KLEMEŠOVÁ, Barbora WEINBERGEROVÁ, Jiří MAYER and Ivana JEŽÍŠKOVÁ. Single cell analýza u pacientů s akutní myeloidní leukemií (Single cell analysis in patients with acute myeloid leukemia). In XXXV. Olomoucké hematologické dny in Transfuze a Hematologie Dnes. 2023. |
Other formats:
BibTeX
LaTeX
RIS
|
Basic information | |
---|---|
Original name | Single cell analýza u pacientů s akutní myeloidní leukemií |
Name (in English) | Single cell analysis in patients with acute myeloid leukemia |
Authors | DRNCOVÁ, Marie (203 Czech Republic, belonging to the institution), A. FOLTA, Iveta KLEMEŠOVÁ (203 Czech Republic), Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Ivana JEŽÍŠKOVÁ (203 Czech Republic, belonging to the institution). |
Edition | XXXV. Olomoucké hematologické dny in Transfuze a Hematologie Dnes, 2023. |
Other information | |
---|---|
Original language | Czech |
Type of outcome | Conference abstract |
Field of Study | 30205 Hematology |
Country of publisher | Czech Republic |
Confidentiality degree | is not subject to a state or trade secret |
RIV identification code | RIV/00216224:14110/23:00131060 |
Organization unit | Faculty of Medicine |
Keywords in English | acute myeloid leukemia; single cell analysis |
Tags | rivok |
Changed by | Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 13/3/2024 09:20. |
Abstract |
---|
Single cell analýza u pacientů s akutní myeloidní leukemií - konferenční abstrakt. |
Abstract (in English) |
---|
Single cell analysis in patients with acute myeloid leukemia - conference abstract. |
Links | |
---|---|
LX22NPO5102, research and development project | Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR) |
Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES | |
MUNI/A/1224/2022, interní kód MU | Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X |
Investor: Masaryk University |
PrintDisplayed: 24/7/2024 11:27